Sun Is Open to Deals in Europe to Boost Scope, Makov Says

Sun Pharmaceutical Industries Ltd. is open to acquisition opportunities in Europe and globally as India’s largest drugmaker by value seeks to add products and extend its geographical reach, Chairman Israel Makov said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.